HIV and antiretroviral therapy in the brain: neuronal injury and repair (Q28279808)

Nature Reviews Neuroscience

Europe PubMed Central

title

HIV and antiretroviral therapy in the brain: neuronal injury and repair (English)

0 references

main subject

brain

0 references

anti-retroviral agent

0 references

0 references

Ronald Ellis

1

0 references

Eliezer Masliah

series ordinal

3

object named as

Eliezer Masliah

0 references

author name string

Dianne Langford

series ordinal

2

0 references

language of work or name

English

0 references

publication date

January 2007

0 references

published in

0 references

volume

8

0 references

issue

1

0 references

page(s)

33-44

0 references

cites work

The neuropathogenesis of AIDS

1 reference

Human macrophages accumulate HIV-1 particles in MHC II compartments

21 April 2017

1 reference

Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection

21 April 2017

1 reference

Overexpression of calbindin D(28k) in dentate gyrus granule cells alters mossy fiber presynaptic function and impairs hippocampal-dependent memory

21 April 2017

1 reference

Human CNS cultures exposed to HIV-1 gp120 reproduce dendritic injuries of HIV-1-associated dementia

21 April 2017

1 reference

Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine

21 April 2017

1 reference

Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine

21 April 2017

1 reference

Fibroblast growth factor 1 regulates signaling via the glycogen synthase kinase-3beta pathway. Implications for neuroprotection

21 April 2017

1 reference

Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART.

21 April 2017

1 reference

Qualitative aspects of verbal fluency in HIV-associated dementia: a deficit in rule-guided lexical-semantic search processes?

21 January 2018

1 reference

Changes in neuropsychological functioning with progression of HIV-1 infection: results of an 8-year longitudinal investigation.

21 January 2018

1 reference

The impact of HIV-associated neuropsychological impairment on everyday functioning

21 January 2018

1 reference

HIV-1 and its causal relationship to immunosuppression and nervous system disease in AIDS: a review.

21 January 2018

1 reference

Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART.

21 January 2018

1 reference

Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.

21 January 2018

1 reference

Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis

21 January 2018

1 reference

21 January 2018

1 reference

Early penetration of the blood-brain-barrier by HIV.

21 January 2018

1 reference

Pathogenesis of lentivirus infections

21 January 2018

1 reference

Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression

21 January 2018

1 reference

Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression

21 January 2018

1 reference

Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage

21 January 2018

1 reference

Human immunodeficiency virus encephalitis and dementia

21 January 2018

1 reference

AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations

21 January 2018

1 reference

Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis

21 January 2018

1 reference

Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center

21 January 2018

1 reference

Synaptic and neuritic alterations during the progression of Alzheimer's disease

21 January 2018

1 reference

Reduced Spinophilin But Not Microtubule-Associated Protein 2 Expression in the Hippocampal Formation in Schizophrenia and Mood Disorders: Molecular Evidence for a Pathology of Dendritic Spines

21 January 2018

1 reference

Borna disease virus replication in organotypic hippocampal slice cultures from rats results in selective damage of dentate granule cells

21 January 2018

1 reference

Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy

21 January 2018

1 reference

Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models.

21 January 2018

1 reference

Elevated neurofilament levels in neurological diseases.

21 January 2018

1 reference

Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss

21 January 2018

1 reference

Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging

21 January 2018

1 reference

Simian immunodeficiency virus: a model for neuroAIDS.

21 January 2018

1 reference

Host response and dysfunction in the CNS during chronic simian immunodeficiency virus infection.

21 January 2018

1 reference

Pathways to neuronal injury and apoptosis in HIV-associated dementia.

21 January 2018

1 reference

The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis

21 January 2018

1 reference

Evidence for calcium-reducing and excitoprotective roles for the calcium-binding protein calbindin-1328k in cultured hippocampal neurons

21 January 2018

1 reference

Ca2+ buffer saturation underlies paired pulse facilitation in calbindin-D28k-containing terminals

21 January 2018

1 reference

Glutamatergic synaptic responses and long-term potentiation are impaired in the CA1 hippocampal area of calbindin D(28k)-deficient mice.

21 January 2018

1 reference

Deficits in memory and hippocampal long-term potentiation in mice with reduced calbindin D28K expression.

21 January 2018

1 reference

Decreased brain dopaminergic transporters in HIV-associated dementia patients

21 January 2018

1 reference

Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.

21 January 2018

1 reference

Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice.

21 January 2018

1 reference

Gp120 can revert antagonism at the glycine site of NMDA receptors mediating GABA release from cultured hippocampal neurons

21 January 2018

1 reference

Highly active antiretroviral therapy and human immunodeficiency virus encephalitis

21 January 2018

1 reference

Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia

21 January 2018

1 reference

Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport

21 January 2018

1 reference

Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide.

21 January 2018

1 reference

Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1.

21 January 2018

1 reference

Upregulation of microglia in drug users with and without pre-symptomatic HIV infection

21 January 2018

1 reference

Methamphetamine stimulates interferon inducible genes in HIV infected brain

21 January 2018

1 reference

Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users

21 January 2018

1 reference

Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons

21 January 2018

1 reference

Enriched environments, experience-dependent plasticity and disorders of the nervous system.

21 January 2018

1 reference

Synaptic activity becomes excitotoxic in neurons exposed to elevated levels of platelet-activating factor

21 January 2018

1 reference

Glial neuronal signaling in the central nervous system

21 January 2018

1 reference

Neuroprotective therapy for HIV dementia

21 January 2018

1 reference

Trophic factor response to neuronal stimuli or injury

21 January 2018

1 reference

Brain-derived neurotrophic factor as a drug target for CNS disorders

21 January 2018

1 reference

AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy

21 January 2018

1 reference

HIV dementia: an evolving disease

21 January 2018

1 reference

Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

21 January 2018

1 reference

Validity of the Quality of Well-Being Scale for persons with human immunodeficiency virus infection. HNRC Group. HIV Neurobehavioral Research Center

21 January 2018

1 reference

Neuropsychologic impairment in early HIV infection. A risk factor for work disability.

21 January 2018

1 reference

Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center

21 January 2018

1 reference

A multimodal assessment of driving performance in HIV infection

21 January 2018

1 reference

Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion

21 January 2018

1 reference

Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years.

21 January 2018

1 reference

Executive functions and the frontal lobes: a conceptual view

21 January 2018

1 reference

Increased glial metabolites predict increased working memory network activation in HIV brain injury

21 January 2018

1 reference

Delayed nonmatch-to-sample performance in HIV-seropositive and HIV-seronegative polydrug abusers.

21 January 2018

1 reference

Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

21 January 2018

1 reference

Adaptation of the attention network in human immunodeficiency virus brain injury

21 January 2018

1 reference

Neural correlates of attention and working memory deficits in HIV patients.

21 January 2018

1 reference

Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients.

21 January 2018

1 reference

Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients

21 January 2018

1 reference

A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

21 January 2018

1 reference

Lithium ameliorates HIV-gp120-mediated neurotoxicity

21 January 2018

1 reference

Neuroprotective and anti-human immunodeficiency virus activity of minocycline

21 January 2018

1 reference

Paradigm shift in neuroprotective drug development: clinically tolerated NMDA receptor inhibition by memantine

21 January 2018

1 reference

Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation.

21 January 2018

1 reference

Cognitive and affective disorders associated to HIV infection in the HAART era: findings from the NeuroICONA study. Cognitive impairment and depression in HIV/AIDS. The NeuroICONA study

21 January 2018

1 reference

Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy.

21 January 2018

1 reference

Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART).

21 January 2018

1 reference

Clinical implications of CNS penetration of antiretroviral drugs

21 January 2018

1 reference

Importance and detection of virus reservoirs and compartments of HIV infection

21 January 2018

1 reference

Expression of brain-derived neurotrophic factor protein in activated microglia of human immunodeficiency virus type 1 encephalitis

21 January 2018

1 reference

Brain-derived neurotrophic factor activation of TrkB protects neurons from HIV-1/gp120-induced cell death

21 January 2018

1 reference

Amelioration of neurotoxic effects of HIV envelope protein gp120 by fibroblast growth factor: a strategy for neuroprotection

21 January 2018

1 reference

Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 are involved in both excitotoxin-induced neurodegeneration and regeneration

21 January 2018

1 reference

Expression of stromal cell-derived factor 1alpha protein in HIV encephalitis

21 January 2018

1 reference

Changes to AIDS dementia complex in the era of highly active antiretroviral therapy

21 January 2018

1 reference

HIV-associated cognitive impairment before and after the advent of combination therapy

31 March 2020

1 reference

Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort

31 March 2020

1 reference

Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.

31 March 2020

1 reference

The central nervous system is a viral reservoir in simian immunodeficiency virus–infected macaques on combined antiretroviral therapy: A model for human immunodeficiency virus patients on highly active antiretroviral theraby

31 March 2020

1 reference

Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center.

31 March 2020

1 reference

Contributions of neuropathology to understanding schizophrenia in late life

31 March 2020

1 reference

Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines

31 March 2020

1 reference

Synaptic transport of human immunodeficiency virus-Tat protein causes neurotoxicity and gliosis in rat brain.

31 March 2020

1 reference

Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment

31 March 2020

1 reference

Neuroprotective strategies for HIV-1-associated neurologic disease

31 March 2020

1 reference

Intrathecal immune activation is associated with cerebrospinal fluid markers of neuronal destruction in AIDS patients

31 March 2020

1 reference

Caspase cascades in human immunodeficiency virus-associated neurodegeneration.

31 March 2020

1 reference

Neuronal apoptosis in HIV infection in adults

31 March 2020

1 reference

Expression of caspase-3 in brains from paediatric patients with HIV-1 encephalitis

31 March 2020

1 reference

The neuropathogenesis of HIV-1 infection

31 March 2020

1 reference

Macrophages/microglia and the pathophysiology of CNS injuries in AIDS

31 March 2020

1 reference

Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains

31 March 2020

1 reference

Monoclonal antibodies directed against the calcium binding protein Calbindin D-28k

31 March 2020

1 reference

Relationship of prefrontal connections to inhibitory systems in superior temporal areas in the rhesus monkey.

31 March 2020

1 reference

Involvement of activated caspase-3-like proteases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons

31 March 2020

1 reference

Experimental and potential future therapeutic approaches for HIV-1 associated dementia targeting receptors for chemokines, glutamate and erythropoietin

31 March 2020

1 reference

The severe combined immunodeficient (SCID) mouse model of human immunodeficiency virus encephalitis: deficits in cognitive function

31 March 2020

1 reference

Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases

31 March 2020

1 reference

Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS.

31 March 2020

1 reference

HIV associated neurodegeneration requires p53 in neurons and microglia.

31 March 2020

1 reference

Patterns of selective neuronal damage in methamphetamine-user AIDS patients

31 March 2020

1 reference

The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease

31 March 2020

1 reference

Effects of hepatic function and hepatitis C virus on the nervous system assessment of advanced-stage HIV-infected individuals

31 March 2020

1 reference

Proliferation and differentiation of adult endogenous neural stem cells in response to neurodegenerative process within the striatum

31 March 2020

1 reference

Leptin enhances NMDA receptor function and modulates hippocampal synaptic plasticity.

31 March 2020

1 reference

The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center.

31 March 2020

1 reference

Effects of immunosuppression and disease severity upon neuropsychological function in HIV infection.

31 March 2020

1 reference

HIV-1 associated neurocognitive disorder. The HNRC Group

31 March 2020

1 reference

Performance of patients with early HIV-1 infection on the Stroop Task

31 March 2020

1 reference

Verbal memory performance of patients with human immunodeficiency virus infection: evidence of subcortical dysfunction. The HNRC Group.

31 March 2020

1 reference

Prospective memory in HIV-1 infection

31 March 2020

1 reference

Lithium improves HIV-associated neurocognitive impairment

31 March 2020

1 reference

Frontal lobe damage and tests of executive processing: a meta-analysis of the category test, stroop test, and trail-making test.

31 March 2020

1 reference

Highly active antiretroviral therapy improves neurocognitive functioning

31 March 2020

1 reference

Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients

31 March 2020

1 reference

Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group

31 March 2020

1 reference

Involvement of alpha1beta1 integrin in insulin-like growth factor-1-mediated protection of PC12 neuronal processes from tumor necrosis factor-alpha-induced injury

31 March 2020

1 reference

The role of leptin in the development of the cerebral cortex in mouse embryos

31 March 2020

1 reference

Cognitive impulsivity and HIV serostatus in substance dependent males

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Changing patterns in the neuropathogenesis of HIV during the HAART era.

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRN2040

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1402447

1046922687

0 references

1402447

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference